We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
+5.75%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
10 Year Est. Return
AUM
$929M
AUM Growth
-$109M
Cap. Flow
-$118M
Cap. Flow %
-12.66%
Top 10 Hldgs %
7.01%
Holding
1,130
New
256
Increased
201
Reduced
274
Closed
399

Top Buys

Rank Stock Value
1
UPBD icon
Upbound Group
UPBD
+$7.28M
2
RAIL icon
FreightCar America
RAIL
+$5.96M
3
CPHD
Cepheid Inc
CPHD
+$5.77M
4
DBRG icon
DigitalBridge
DBRG
+$5.69M
5
SPXC icon
SPX Corp
SPXC
+$5.56M

Sector Composition

Rank Sector Weight
1 Healthcare 22.43%
2 Technology 14.1%
3 Industrials 13.01%
4 Consumer Discretionary 12.84%
5 Financials 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAX
701
abrdn Asia-Pacific Income Fund
FAX
$597M
$50K 0.01%
+1,815
New +$50K
MDR
702
DELISTED
McDermott International
MDR
$50K 0.01%
+4,968
New +$68.1K
ANTH
703
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$50K 0.01%
+1,351
New +$59.6K
EXK
704
Endeavour Silver
EXK
$2.35B
$47K 0.01%
33,232
-4,973
-13% -$7.71K
WG
705
DELISTED
Willbros Group
WG
$47K 0.01%
17,299
-40,675
-70% -$98.5K
MHGC
706
DELISTED
Morgans Hotel Group Co.
MHGC
$47K 0.01%
+13,822
New +$47.1K
ENPH icon
707
Enphase Energy
ENPH
$5.01B
$46K 0.01%
+12,999
New +$40.6K
COOP
708
DELISTED
Mr. Cooper
COOP
$45K ﹤0.01%
+1,451
New +$43.1K
VIRX
709
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$45K ﹤0.01%
238
-859
-78% -$161K
CTCM
710
DELISTED
CTC MEDIA INC COM STK
CTCM
$43K ﹤0.01%
23,309
-178,499
-88% -$320K
ORIG
711
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
$43K ﹤0.01%
3
-14
-82% -$250K
EGIO
712
DELISTED
Edgio, Inc. Common Stock
EGIO
$42K ﹤0.01%
715
-6,370
-90% -$476K
SXC icon
713
SunCoke Energy
SXC
$765M
$41K ﹤0.01%
11,715
-350,779
-97% -$1.68M
TROX icon
714
Tronox
TROX
$973M
$41K ﹤0.01%
+10,362
New +$57K
EIGR
715
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$41K ﹤0.01%
63
-102
-62% -$57.7K
MEMP
716
DELISTED
Memorial Production Partners LP Common Units
MEMP
$39K ﹤0.01%
14,838
-44,305
-75% -$189K
AXAS
717
DELISTED
Abraxas Petroleum Corp
AXAS
$35K ﹤0.01%
1,666
-17,115
-91% -$471K
CPXX
718
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$34K ﹤0.01%
19,406
-3,037
-14% -$5.21K
ONE
719
DELISTED
HIGHER ONE HOLDINGS, INC COM STK
ONE
$34K ﹤0.01%
10,416
-17,058
-62% -$48.7K
PLX icon
720
Protalix BioTherapeutics
PLX
$193M
$32K ﹤0.01%
+3,123
New +$31.8K
ALIM
721
DELISTED
Alimera Sciences
ALIM
$32K ﹤0.01%
+894
New +$38.8K
PACD
722
DELISTED
Pacific Drilling S A
PACD
$32K ﹤0.01%
3,844
-154
-4% -$2.04K
CPRX
723
DELISTED
Catalyst Pharmaceutical
CPRX
$31K ﹤0.01%
+12,662
New +$36.3K
MR
724
DELISTED
Montage Resources Corporation Common Stock
MR
$31K ﹤0.01%
1,137
-10,812
-90% -$382K
AKS
725
DELISTED
AK Steel Holding Corp
AKS
$24K ﹤0.01%
10,696
-393,068
-97% -$987K

Similar funds

TFS Capital's Q4 2015 Portfolio in Review

As of Q4 2015, TFS Capital held 1,130 positions worth $929M, down 10% from $1.04B the previous quarter. Its ten largest holdings account for 7% of the portfolio.

TFS Capital withdrew a net $118M in Q4 2015, closing 399 positions and reducing 274 holdings. Its most notable exit was ePlus, an estimated $7.35M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

Against the trend, TFS Capital opened a new position in Upbound Group worth $5.71M.

  • TFS Capital's largest Q4 2015 buy was Upbound Group: 381,410 shares worth $5.71M.
  • TFS Capital added most to SPX Corp in Q4 2015, an estimated $5.56M increase.
  • TFS Capital's biggest Q4 2015 reduction was Concert Pharmaceuticals, Inc., cutting an estimated $6.04M.
  • TFS Capital fully exited ePlus in Q4 2015, selling an estimated $7.35M.
  • TFS Capital's ten largest holdings make up 7% of its $929M portfolio in Q4 2015.
  • TFS Capital opened 256 new positions and closed 399 in Q4 2015.
  • TFS Capital's portfolio value fell 10% quarter-over-quarter to $929M.

Based on TFS Capital's 13F filing for Q4 2015, filed 29 Jan 2016.